Panel Discussion: Regenerative Medicine Use Across Species - Best Practices and Case Examples

Friday, October 24, 2025

5:15 PM - 6:00 PM

Speaker(s)

Heidi Reesink, VMD, PhD, DACVS (Large Animal)

Professor of Veterinary Orthopedics
University of California, Davis
Davis, California

Guest Speaker(s)

Christopher Frye, DVM, DACVSMR (he/him/his)

Associate Professor, Section Chief Sports Medicine & Rehabilitation
Cornell University College of Veterinary Medicine
Ithaca, New York
William King, PhD

Zoetis

Speaker(s)

Laurie R. Goodrich, DVM, PhD, DACVS (she/her/hers)

Professor, Equine Surgery and Lameness
Colorado State University College of Veterinary Medicine & Biomedical Sciences
Fort Collins, Colorado
Kyla F. Ortved, DVM, PhD, DACVS (Large Animal), DACVSMR

Associate Professor Of Large Animal Surgery, Jacques Jenny Endowed Term Chair in Orthopedic Surgery
University of Pennsylvania School of Veterinary Medicine
Kennett Square, Pennsylvania

Advances in human regenerative medicine technologies continue to bring exciting new options for patients and physicians. This lecture will provide a summary of recent clinical results from human clinical trials of regenerative medicine devices, autologous and allogeneic cell therapies, gene therapies, and other “advanced” therapies. Key challenges to translating these technologies include long development and clinical testing timelines, high manufacturing costs, and poorly defined paths to reimbursement. Keeping a “One Health” framework in mind when developing and testing future regenerative medicine technologies could help address these limitations.